LarissaAMeyerMDMPH(She/Her)
Obstetrics & Gynecology • Houston, TXGynecologic Oncology
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston
Dr. Meyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6810
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2007 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Obstetrics and Gynecology, 2002 - 2006
Harvard Medical SchoolClass of 2002
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2008 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
- Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer Start of enrollment: 2018 Sep 11
Publications & Presentations
PubMed
- Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study.Reem Saab, Bryan M Fellman, Alejandra Flores Legarreta, Larissa A Meyer, Nicole D Fleming
Gynecologic Oncology. 2024-12-01 - Healthcare Costs in the United States by Demographic Characteristics and Comorbidity Status.Naomi N Adjei, Allen Haas, Charlotte C Sun, Hui Zhao, Paul G Yeh
Value in Health. 2024-11-10 - Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer.Sarah Huepenbecker, Larissa A Meyer, Miranda Craft, John K Chan, Christopher Craggs
International Journal of Gynecological Cancer. 2024-11-04
Journal Articles
- A Prospective Randomized Trial Comparing Liposomal Bupivacaine vs. Standard Bupivacaine Wound Infiltration in Open Gynecologic Surgery on an Enhanced Recovery PathwayLarissa A Meyer, Javier Lasala, Gabriel Mena, American Journal of Obstetrics and Gynecology
Authored Content
- A Prospective Randomized Trial Comparing Liposomal Bupivacaine vs. Standard Bupivacaine Wound Infiltration in Open Gynecologic Surgery on an Enhanced Recovery PathwayJuly 2020
- A Prospective Randomized Trial Comparing Liposomal Bupivacaine vs. Standard Bupivacaine Wound Infiltration in Open Gynecologic Surgery on an Enhanced Recovery PathwayJuly 2020
Press Mentions
- "Author Reply to "Commentary on A Specific Bacterial DNA Signature in the Vagina of Australian Women in Midpregnancy Predicts High Risk of Spontaneous Preterm Birth (The Predict1000 Study)""February 6th, 2021
- Patient Cost-Sharing During Poly(ADP-Ribose) Polymerase Inhibitor Treatment in Ovarian CancerFebruary 4th, 2021
Neoadjuvant Chemo Optimal Choice for Some Women with Ovarian CancerSeptember 8th, 2016- Join now to see all
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
